DeepMed Research

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

Phase 4

Completed

Conditions: Bleeding
Implants
Breakthrough Bleeding

Interventions: Drug: Tamoxifen
Drug: Placebo
Drug: Tamoxifen (open label)

First Posted Date: 2016-09-16

Last Posted Date: 2020-07-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 109

Registration Number: NCT02903121

Locations: 🇺🇸
OHSU, Portland, Oregon, United States

Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Free From Falls Online
Behavioral: Waitlist Control

First Posted Date: 2016-08-31

Last Posted Date: 2018-04-09

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 30

Registration Number: NCT02885233

Locations: 🇺🇸
Oregon Health Sciences University, Portland, Oregon, United States

Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury

Not Applicable

Active, not recruiting

Conditions: Spinal Cord Injury

Interventions: Other: Augmented Blood Pressure

First Posted Date: 2016-08-25

Last Posted Date: 2023-12-05

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 152

Registration Number: NCT02878850

Locations: 🇺🇸
Atrium Health F.H. Sammy Ross Trauma Center, Charlotte, North Carolina, United States
🇺🇸
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

and more 8 locations

Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization

Conditions: Peripheral Artery Disease

Interventions: Other: Contrast ultrasound perfusion imaging of the limb

First Posted Date: 2016-08-24

Last Posted Date: 2018-08-23

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 30

Registration Number: NCT02877563

Locations: 🇺🇸
OHSU, Portland, Oregon, United States

Four Way Crossover Closed Loop With Exercise Detection

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Artificial Pancreas Controller in Single Hormone Mode
Device: Artificial Pancreas Controller in Predictive Low Glucose Suspend Mode
Device: Artificial Pancreas Controller in Dual Hormone Mode
Device: Subject's insulin pump

First Posted Date: 2016-08-11

Last Posted Date: 2018-09-14

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 25

Registration Number: NCT02862730

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG

Phase 4

Completed

Conditions: Obesity

Interventions: Drug: Levonorgestrel-based emergency contraception 1.5 mg
Drug: Levonorgestrel-based emergency contraception 3.0mg

First Posted Date: 2016-08-11

Last Posted Date: 2023-06-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 70

Registration Number: NCT02863445

Locations: 🇺🇸
OHSU, Portland, Oregon, United States

The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications

Phase 4

Completed

Conditions: Neuromuscular Blockade
Postoperative Complications

Interventions: Drug: Sugammadex
Drug: Neostigmine

First Posted Date: 2016-08-10

Last Posted Date: 2020-03-31

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 200

Registration Number: NCT02861131

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

Phase 4

Completed

Conditions: Obesity
Contraception

Interventions: Drug: UPA-ECx1
Drug: UPA-ECx2

First Posted Date: 2016-08-09

Last Posted Date: 2024-02-06

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 64

Registration Number: NCT02859337

Locations: 🇺🇸
OHSU, Portland, Oregon, United States

Magnesium Sulfate in Obese Preeclamptics

Phase 4

Completed

Conditions: Preeclampsia

Interventions: Drug: Magnesium sulfate 6g loading dose, 2g/hr infusion
Drug: Magnesium sulfate 4g loading dose, 1g/hr infusion

First Posted Date: 2016-07-18

Last Posted Date: 2020-05-13

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 66

Registration Number: NCT02835339

Locations: 🇺🇸
Oregon Health & Science Univerity, Portland, Oregon, United States

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Phase 4

Completed

Conditions: Metrorrhagia
Menorrhagia
Medicated Intrauterine Devices

Interventions: Drug: Tamoxifen
Drug: Placebo (for Tamoxifen)

First Posted Date: 2016-07-06

Last Posted Date: 2019-06-04

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 42

Registration Number: NCT02824224

Locations: 🇺🇸
OHSU Center For Women's Health, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy